Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;54(10):837-844.
doi: 10.1007/s00535-019-01604-7. Epub 2019 Jul 24.

Eosinophilic Esophagitis: Novel Concepts Regarding Pathogenesis and Clinical Manifestations

Affiliations
Free PMC article
Review

Eosinophilic Esophagitis: Novel Concepts Regarding Pathogenesis and Clinical Manifestations

Stuart Jon Spechler. J Gastroenterol. .
Free PMC article

Abstract

This report explores two hypotheses regarding eosinophilic esophagitis (EoE): (1) that the use of proton pump inhibitors (PPIs) might contribute to the pathogenesis of EoE by preventing peptic digestion of food allergens, by increasing gastric mucosal permeability to enable gastric absorption of those undegraded food allergens, and by causing microbial dysbiosis, and (2) that EoE, like eosinophilic gastroenteritis, might have mucosal-predominant and muscle-predominant forms, and that the muscle-predominant form of EoE might cause a variety of esophageal motility disorders including achalasia.

Keywords: Achalasia; Esophageal motility; Proton pump inhibitors.

Conflict of interest statement

Dr. Spechler serves as a consultant for Ironwood Pharmaceuticals, Frazier Life Sciences, and Interpace Diagnostics.

Figures

Fig. 1
Fig. 1
Potential mechanisms underlying the association of esophageal motility abnormalities and esophageal eosinophilia. a Primary esophageal motility abnormalities cause esophageal stasis with retained material that irritates the mucosa, inducing secretion of chemokines that attract eosinophils. b Motility abnormalities are caused by eosinophils in the esophagus that release myoactive, neuroactive, and pro-fibrotic eosinophil secretory products. c Motility abnormalities are caused by eosinophils in the esophagus that release cytotoxic eosinophil secretory products that destroy esophageal intramural neurons Modified illustration of esophagus and stomach used with permission, copyright, American Gastroenterological Association Institute, Bethesda, MD, and figure reproduced from reference 27 with permission from the American Journal of Gastroenterology

Similar articles

See all similar articles

References

    1. Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–116. doi: 10.1007/BF01296781. - DOI - PubMed
    1. Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319–322. doi: 10.1053/j.gastro.2017.06.067. - DOI - PMC - PubMed
    1. Dellon ES, Erichsen R, Baron JA, et al. The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther. 2015;41:662–670. doi: 10.1111/apt.13129. - DOI - PMC - PubMed
    1. Arias A, Perez-Martinez I, Tenias JM, et al. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43:3–15. doi: 10.1111/apt.13441. - DOI - PubMed
    1. Dellon ES, Jensen ET, Martin CF, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12:589–596. doi: 10.1016/j.cgh.2013.09.008. - DOI - PMC - PubMed

LinkOut - more resources

Feedback